Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

An oncology pharmacist shares how a treatment takes a different approach to treating chronic graft-versus-host disease (GVHD) ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

A history of foot or ankle injury is a major risk factor for osteoarthritis in those joints among former soccer players in ...

Researchers have found in a new study that Lichen sclerosus is linked to a significantly increased risk of vulvar dysplasia ...

London-based drugmaker GSK has announced the UK approval of Nucala (mepolizumab) as an add-on maintenance biologic treatment ...

After a weekend of very high tree pollen counts and cedar fever, this week might not be as bad. Here's what you can do if you ...

Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease: London, UK Tuesday, January 6, 2026, 10:00 Hrs [IST] GSK plc announced that China’ ...

A single center letter describes lung transplantation in people living with HIV despite CD4 counts under 200 during evaluation, emphasizing prior viral suppression and clinical context when assessing ...

A Canadian real-world study reveals high oral corticosteroid exposure in patients with severe chronic rhinosinusitis with ...